Business Standard
Friday, Jun 01, 2012
Sponsored by  
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||Economy & Policy||||| 
 Section Home | News Now | Today's Paper | Features & Analysis | Politics & Public Affairs | Q&A | Columnists | BS Says
Home > Economy & Policy Live Markets | Commodities
 

UK keen on strong bonds with Indian drug controllers for quality
BS Reporter / Chennai/ Bangalore Sep 19, 2009, 00:09 IST

The United Kingdom (UK), which prides itself in being a major centre for drug research, has great interest in building up a strong relationship with the Drug Controller General of India.

This is not because India is considered a major centre for drug research, but, because about one-fourth of the volume of generic drugs sold in UK are those imported from India.

About two-thirds of the products sold in the UK are generic. “That’s why we are interested in building up a strong relationship with the Drug Controller of India and the respective drug controllers in the major states,” said Gerald W Heddell, director, inspection enforcement and standards division, Medicines and Healthcare Products Regulatory Authority, UK.

The UK’s centralised healthcare system, National Health Service (NHS), is the world’s biggest health service. UK is interested in ensuring that they have only quality products being imported.

The UK government wants strong links with the Indian regulators. That is one reason why Indian drug producing companies are also of great importance for the UK.

A team from the UK was in India to exchange information with the Drugs Controller of India and also some of the state drug controllers.

Meanwhile, the UK, which has great strength in clinical research, is trying to attract clinical research firms from India to set up labs or for doing clinical research in the UK. It is also keen on promoting itself as a drug manufacturing centre.

According to a report from Ernst & Young 2007, UK was the leader in biotech sector in Europe with 40 per cent of EU’s public biotech companies.

The UK has established end-to-end capability in bringing products to market.

It accounts for about 35 per cent of the European drugs in clinical trial pipeline. In the UK, the government funding for clinical research is expected to rise to 1.7 billion pounds per annum by 2010.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets post worst May performace since 2006
- US jobs data points to recovery losing momentum
- FII-TO-FII TRADES: PNB traded at 5% premium
- Sugar output up at 25.5 million tonne this year surpasses govt estimate
- CoalMin identifies 54 blocks for allocation through auction
  Read Business news in 
- Help a Child Achieve her. Click to know more
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- Watch The Film Here. Click here to know more..
- 1 billion in saving for Unilever without any tangles.
- One Partnership Endless Possibilities. Click here to know more
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Slowdown gets worse, GDP growth sinks to 9-year low
- India Inc ready to shift to other side of the dot on www
- M&M has a Rs 7,500-cr spending plan over three years
- India to be $2-trn economy by FY13-end?
- IIT alumni to move court on changes in JEE
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  Hot Searches  
 
Apalya |  Air India |  GAAR |  Agni  |  Solar eclipse |  Satyamev Jayate |  SRK |  Aamir Khan |  IPL |  Ertiga |  Sarfaesi Act |  Vodafone |  JP Morgan |  Transfer pricing |  Rupee |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us